Laurie Alsup
Director/Board Member at BLACKBERRY LIMITED
Net worth: 587 985 $ as of 2024-04-29
Laurie Alsup active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BLACKBERRY LIMITED | Director/Board Member | 2015-06-22 | - |
| Independent Dir/Board Member | 2015-06-22 | - | |
| THERAVANCE BIOPHARMA, INC. | Director/Board Member | 2018-02-12 | - |
| Independent Dir/Board Member | 2018-02-12 | - | |
| ARVINAS, INC. | Director/Board Member | 2019-11-19 | - |
| Independent Dir/Board Member | 2019-11-19 | - | |
NDA Group AB
 NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Corporate Officer/Principal | 2023-07-31 | - |
| Chief Operating Officer | 2016-02-29 | 2019-02-28 | |
| Chief Tech/Sci/R&D Officer | 2016-02-29 | 2023-07-31 | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Director/Board Member | - | - |
Career history of Laurie Alsup
Former positions of Laurie Alsup
| Companies | Position | Start | End |
|---|---|---|---|
| KINNATE BIOPHARMA INC. | Director/Board Member | 2020-07-31 | 2024-04-02 |
| Independent Dir/Board Member | 2020-07-31 | 2024-04-02 | |
| PARDES BIOSCIENCES, INC. | Director/Board Member | 2022-09-13 | 2023-08-29 |
| Independent Dir/Board Member | - | 2023-08-29 | |
PharmApprove LLC
 PharmApprove LLC Miscellaneous Commercial ServicesCommercial Services PharmApprove LLC provides strategic regulatory and scientific communications consultancy services to the pharmaceutical and biotech industries. The firm offers both strategic and tactical support to companies facing high-profile, high stakes events and engagements anywhere along the road to approval and commercialization -including FDA Advisory Committee meetings. The company was founded by Pete Taft in 1999 and is headquartered in Lawrenceville, NJ. | Chief Tech/Sci/R&D Officer | 2011-07-31 | 2016-02-29 |
| President | 2011-07-31 | 2016-02-29 | |
| HUMANIGEN, INC. | Director/Board Member | 2013-10-21 | 2015-11-19 |
| Independent Dir/Board Member | 2013-10-21 | 2015-11-19 | |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Laurie Alsup
| Fordham University | Undergraduate Degree |
| Yale School of Medicine | Doctorate Degree |
Statistics
International
| United States | 13 |
| Canada | 2 |
| Sweden | 2 |
Operational
| Director/Board Member | 8 |
| Independent Dir/Board Member | 6 |
| President | 2 |
Sectoral
| Health Technology | 9 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| HUMANIGEN, INC. | Health Technology |
| BLACKBERRY LIMITED | Technology Services |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| ARVINAS, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Phytomedics, Inc.
 Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | Health Technology |
PharmApprove LLC
PharmApprove LLC Miscellaneous Commercial ServicesCommercial Services PharmApprove LLC provides strategic regulatory and scientific communications consultancy services to the pharmaceutical and biotech industries. The firm offers both strategic and tactical support to companies facing high-profile, high stakes events and engagements anywhere along the road to approval and commercialization -including FDA Advisory Committee meetings. The company was founded by Pete Taft in 1999 and is headquartered in Lawrenceville, NJ. | Commercial Services |
NDA Group AB
NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Commercial Services |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat and prevent viral diseases. It also focuses on developing novel drugs to solve pandemic-sized problems like the coronavirus disease. The company was founded by Uri A. Lopatin and Lee D. Arnold on February 27, 2020 and is headquartered in Carlsbad, CA. | Health Technology |
| Kalobios Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Laurie Alsup
- Experience